Stock Market Most Active AMEX Stocks Tuesday, December 10, 2013

New Post Public Reply Private Reply Replies (0) Message Board
Polgar
AMEX Most Active 

SYMBOL NAME PRICE ($) CHANGE % CHANGE VOLUME
SPY SPDR S&P 500 180.80 -0.60 -0.33%  26,941,529
GDX Market Vectors Gold Miners ETF 22.10 +0.89 +4.20%  24,172,642
EEM iShares MSCI Emerging Index Fund 41.89 -0.11 -0.25%  16,422,350
XLF SPDR Select Sector Fund - Financial 21.44 -0.04 -0.20%  14,095,710
IWM iShares Russell 2000 ETF 111.54 -0.92 -0.81%  13,514,259
EWJ iShares MSCI Japan Index Fund 11.92 -0.03 -0.21%  8,799,739
FXI iShares FTSE China 25 Index Fund 39.59 -0.30 -0.74%  8,192,534
VWO Vanguard FTSE Emerging Markets ETF 41.28 -0.06 -0.13%  7,771,476
XLE SPDR Select Sector Fund - Energy Select Sector 86.31 -0.22 -0.25%  6,457,426
XLI SPDR Select Sector Fund - Industrial 50.48 +0.01 +0.01%  6,032,436
XLK SPDR Select Sector Fund - Technology 34.85 -0.09 -0.24%  5,113,995
NUGT Direxion Daily Gold Miners Bull 3X Shares 31.05 +3.63 +13.24%  4,961,717
ANV Allied Nevada Gold Corp. 3.60 +0.39 +12.15%  4,726,240
GLD SPDR Gold Trust 121.72 +2.00 +1.67%  4,717,227
EFA iShares MSCI EAFE ETF 65.04 -0.26 -0.39%  4,705,967
HEB Hemispherx BioPharma Inc 0.28 -0.04 -12.22%  4,582,156
TZA DIREXION DLY SM CAP BEAR 3X 19.20 +0.46 +2.44%  4,546,186
NAVB Navidea Biopharmaceuticals I 2.08 +0.25 +13.62%  4,413,667
SLV iShares Silver Trust 19.59 +0.47 +2.46%  4,276,400
XLU SPDR Select Sector Fund - Utilities 37.87 -0.34 -0.89%  3,989,629
TNA Direxion Small Cap Bull 3x Shares 70.67 -1.73 -2.39%  3,975,367
EWZ iShares MSCI Brazil Capped Index Fund 45.62 +0.10 +0.22%  3,891,510
XOP SPDR S&P Oil & Gas Explor & Product 66.73 +0.66 +0.99%  3,873,932
UVXY ProShares Trust Ultra VIX Short Term Futures ETF 18.96 +0.21 +1.12%  3,669,464
UNG United States Natural Gas Fund LP 20.75 +0.05 +0.24%  3,598,286
TPLM Triangle Pete Corp 10.13 -0.54 -5.06%  2,601,060
LNG Cheniere Energy Inc 44.30 -0.48 -1.07%  2,571,653
USO United States Oil Fund 35.17 +0.26 +0.74%  2,511,659
SSO ProShares Ultra S&P500 97.45 -0.63 -0.64%  2,503,972
SDS ProShares UltraShort S&P500 31.35 +0.21 +0.67%  2,490,076
OIH Market Vectors Oil Services ETF 47.59 -0.41 -0.85%  2,376,522
FAZ Direxion Financial Bear 3X Shares 23.46 +0.16 +0.69%  2,246,894
NGD New Gold Inc. 5.25 +0.35 +7.04%  2,185,027
ITB iShares U.S. Home Construction ETF 22.92 +0.06 +0.26%  2,149,923
TLT iShares 20 Year Treasury Bond ETF 103.61 +0.45 +0.44%  2,149,575
VTG Vantage Drilling Co 1.80 -0.01 -0.55%  2,106,048
IYR iShares U.S. Real Estate ETF 63.89 +0.08 +0.13%  2,087,032
TBT ProShares UltraShort Lehman 20 Year Treasury 77.28 -0.79 -1.01%  2,034,312
ONVO Organovo Hldgs Inc 9.93 -0.17 -1.68%  1,982,593
DUST Direxion Daily Gold Miners Bear 3X Shares 40.77 -6.08 -12.98%  1,948,369
EZU iShares MSCI EMU Index Fund 39.46 -0.16 -0.40%  1,943,668
DXJ WisdomTree Japan Hedged Equity Fund 49.75 -0.36 -0.72%  1,848,912
DJP iPath Dow Jones UBS Commodity Index Total Return ETN 37.14 +0.18 +0.49%  1,798,220
IAU ishares Gold Trust 12.24 +0.21 +1.75%  1,796,698
EPI WisdomTree India Earnings Fund 17.48 -0.16 -0.91%  1,663,704
XLV SPDR Select Sector Fund - Health Care 55.11 -0.22 -0.40%  1,636,189
DIA SPDR Dow Jones Industrial Average ETF 159.73 -0.50 -0.31%  1,635,016
XLP SPDR Select Sector Fund - Consumer Staples 42.76 -0.47 -1.09%  1,603,815
NG NovaGold Resources Inc 2.42 +0.13 +5.76%  1,544,996
FAS Direxion Financial Bull 3X Shares 83.70 -0.50 -0.59%  1,531,665
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 454

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 59

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 283

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 493

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 66

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 77

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Ventas to Showcase Investment Strategy at Real Estate Conference

Updated Category News Views 44

Ventas Engages Investors at Upcoming Conference Ventas, Inc. (NYSE: VTR) is gearing up to take part in significant investor meetings at the BofA Securities 2024 Global Real Estate Conference. This event presents a valuable chance for the company to connect with investors and share insights about its strategic direction and business model. Event Details and Participation...

Continue Reading
BioLineRx Explores Synergy in Ovarian Cancer Treatment

Updated Category News Views 151

New Hope on the Ovarian Cancer Front Every so often, something comes along and makes you stop and think—could this be the game-changer in the making? Well, what BioLineRx Ltd. (NASDAQ: BLRX) and Hemispherian AS just dropped at the ESMO 2026 feels a bit like that silver lining for folks fighting the uphill battle against homologous recombination (HR)-proficient ovarian...

Continue Reading
Analyst Ratings Show Confidence in Datadog and Others

Updated Category News Views 80

Recent Upgrades by Top Analysts Leading financial analysts from Wall Street have adjusted their outlooks on several prominent companies, reflecting a more optimistic market sentiment. Upgrades often signify increased confidence in a company's performance and present potential investment opportunities for savvy investors. Here, we delve into some of the standout upgrades...

Continue Reading
Unpacking the Increased Short Interest in Ventas (NYSE: VTR)

Updated Category News Views 77

Understanding Ventas's Short Interest Surge Ventas recently recorded an uptick in its short percent of float, which now stands at 25.59% since the last report. This notable development means that 9.80 million shares are currently sold short, translating to 3.19% of all regular shares available for trading. Given the trading volume, it would take traders approximately 3.33...

Continue Reading
Precigen's PAPZIMEOS: 7-Year Exclusivity & Long-Term Success

Updated Category News Views 54

Precigen's Game-Changer: PAPZIMEOS Secures Seven-Year Exclusivity Here's how you carve out a solid niche in the biotech world: deliver some killer results and snag yourself seven years in the driver’s seat. That's exactly what Precigen (NASDAQ: PGEN) has done with their PAPZIMEOS therapy, which got the stamp of approval from the FDA as the first exclusive treatment for...

Continue Reading